RYDAPT (midostaurin)
ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ACUTE MYELOID LEUKEMIA WITH FMS-LIKE TYROSINE KINASE-3 (FLT3) MUTATION ·+3
Novartis Pharmaceuticals